Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Dynomics
AddedFeb 18, 2024
UpdatedJun 18, 2026
Dynomics

Dynomics

Pre-Seed

Dynomics: Precision drug development for heart function, leveraging HeartDyno, our predictive discovery engine, to improve heart failure treatments.

HQ
San Mateo, CA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Dynomics was founded with the mission to revolutionize heart failure treatment through precision drug development. The company focuses on targeting therapeutics to human heart function, employing a data-driven approach powered by its proprietary HeartDyno discovery engine. HeartDyno utilizes engineered human cardiac organoids to uncover novel therapeutic targets and candidates, aiming to offer superior efficacy and safety profiles. Dynomics' market focus is on developing targeted therapies to eliminate heart failure, addressing the critical need for better treatment options beyond symptomatic relief.

Notable affiliated people and investors include experts in cardiology and biotechnology, though specific names are not provided. Key achievements of Dynomics include the scalable deployment of HeartDyno, which has significantly advanced the discovery of effective heart failure treatments. The overall impact of Dynomics lies in its potential to improve prognosis for heart failure patients by developing therapies that restore heart function, thereby addressing a leading cause of death globally.

Dynomics - Similar Companies

Dynocardia logo

Dynocardia

dynocardia.care

Organos logo

Organos

organosinc.com

Dynosense logo

Dynosense

dynosense.com

Cydan logo

Cydan

cydanco.com

Ventrinova logo

Ventrinova

Vivodyne logo

Vivodyne

vivodyne.com

Xdynia logo

Xdynia

Cardurion Pharmaceuticals logo

Cardurion Pharmaceuticals

i-Cordis logo

i-Cordis

KinoDyn logo

KinoDyn

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

Equator Therapeutics logo

Equator Therapeutics

Vital Labs logo

Vital Labs

vitallabs.co

Animated Dynamics logo

Animated Dynamics

anidyn.com

Impulse Dynamics logo

Impulse Dynamics

Dynomics - Quick Facts

Who are Dynomics' competitors?

Companies similar to Dynomics include Dynocardia, Organos, Dynosense and Cydan.

When was Dynomics founded?

Dynomics was founded in 2020.

Where is Dynomics' headquarters located?

Dynomics' headquarters is located in San Mateo, CA, US.

When was Dynomics' last funding round?

Dynomics' most recent funding round was for $500k (USD) in October 2020.

How much has Dynomics raised to-date?

As of Oct 17, 2020, Dynomics has raised a total of $500k (USD).

How many employees does Dynomics have?

Dynomics has 11 employees as of Feb 4, 2024.

Dynomics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified